tiprankstipranks
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Holding ENTA?
Track your performance easily

Enanta Pharmaceuticals (ENTA) Financial Statements

160 Followers

Enanta Pharmaceuticals Financial Overview

Enanta Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.486; its P/E ratio is -1.64; Enanta Pharmaceuticals is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $-1.25. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 17.97M$ 18.00M$ 18.89M$ 17.80M$ 23.59M
Gross Profit$ 17.97M$ 18.00M$ 18.89M$ 17.80M$ 23.59M
EBIT$ -20.70M$ -30.59M$ -32.85M$ -37.61M$ -29.02M
EBITDA$ -20.40M$ -29.95M$ -30.85M$ -37.07M$ -28.85M
Net Income Common Stockholders$ -22.66M$ -33.41M$ -39.06M$ -37.66M$ -28.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 230.09M$ 337.15M$ 386.58M$ 210.08M$ 214.47M
Total Assets$ 398.82M$ 428.50M$ 495.17M$ 326.44M$ 347.53M
Total Debt$ 50.57M$ 25.49M$ 27.70M$ 28.00M$ 25.34M
Net Debt$ -179.52M$ -311.66M$ -358.88M$ -182.09M$ -189.13M
Total Liabilities$ 248.48M$ 236.62M$ 257.35M$ 55.65M$ 46.70M
Stockholders Equity$ 150.34M$ 191.88M$ 237.82M$ 270.80M$ 300.84M
Cash Flow-
Free Cash Flow$ -21.32M$ -25.77M$ -34.28M$ -16.17M$ -38.80M
Operating Cash Flow$ -14.78M$ -24.99M$ -32.13M$ -13.78M$ -35.64M
Investing Cash Flow$ -6.34M$ -13.12M$ -145.75M$ 46.77M$ 33.57M
Financing Cash Flow$ -6.65M$ -7.35M$ 199.88M$ -2.03M$ 301.00K
Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History

Enanta Pharmaceuticals Debt to Assets

Enanta Pharmaceuticals Cash Flow

Enanta Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis